DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more
Drugs by Name Drugs by Condition Drugs by Category Most Searched Ratings/Reviews Active Ingred's Alerts Adverse Events

Aranesp (Erythropoiesis Stimulating Protein) - FDA Alerts

Aranesp Rx
FDA Alerts Summary Description and Clinical Pharmacology Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Other Rx Information Adverse Event Reports
 

Aranesp News
News in Media Published Studies Curr't Clinical Trials



FDA Alerts related to Aranesp (Erythropoiesis Stimulating Protein)

FDA Alert [11/8/2007]: FDA is issuing this alert to update healthcare professionals about revisions to the product labeling for the erythropoiesis-stimulating agents (ESAs) [Aranesp (darbepoetin alfa), Epogen (epoetin alfa), and Procrit (epoetin alfa)]. These revisions are intended to clarify the evidence for safety and effectiveness and provide more explicit directions and recommendations to prescribers on their use. More information

This information reflects FDA’s preliminary analysis of data concerning this drug. FDA is considering, but has not reached a final conclusion about, this information. FDA intends to update this sheet when additional information or analyses become available.

For complete, up-to-date safety information by the FDA, see MedWatch

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009